Commodore Capital’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Commodore Capital’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,711,286	Closed	-$22.3M	–	39
2022 Q3	$22.3M	Hold	3,711,286	–	–	3.58%	9
2022 Q2	$15.4M	Hold	3,711,286	–	–	3.25%	12
2022 Q1	$14.1M	Hold	3,711,286	–	–	3.15%	12
2021 Q4	$16.7M	Buy	3,711,286 +592,525	+19%	+$3.01M	3.87%	11
2021 Q3	$14.5M	Buy	3,118,761 +22,032	+0.7%	+$117K	3.83%	11
2021 Q2	$21.8M	Buy	3,096,729 +665,024	+27%	+$3.59M	7.61%	2
2021 Q1	$14.4M	Buy	+2,431,705	New	+$14.7M	5.72%	4

Other funds holding STSA

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Commodore Capital's STSA Position: Q4 2022 in Review

Commodore Capital sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q4 2022, closing a stake of 3,711,286 shares — an estimated $22.3M sold.

Commodore Capital first reported a position in STSA in Q1 2021 and held it in 7 quarters. The position peaked at $22.3M in Q3 2022. 32 funds tracked by Wall St. Rank hold STSA as of Q4 2022.

Commodore Capital reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Commodore Capital sold 3,711,286 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $22.3M.
Commodore Capital first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Commodore Capital's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $22.3M in Q3 2022.
32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Commodore Capital's 13F filing for Q4 2022, filed 14 Feb 2023.